Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Image of foreigners being arrested in S.Africa during Eid is AI-generated - 2French lawmakers narrowly approve health care budget, suspending Macron's flagship pension reform
- 3What Yogurt Types Do You Know
- 4Barn Stored Lotus Esprit Turbo Seen After 30 Years
- 5Danish warship sunk by famed British admiral discovered after 225 years
- Vote in favor of your Favored Kind of Scarf
- How to watch 'Tell Me Lies' Season 3: Episode release times, streaming info and more
- Extraordinary Guinness World Records That Will Astound You
- Ukraine confirms defence and energy ministers at second attempt
- IDF finds weapon of slain hostage Capt. Daniel Perez in booby-trapped Gaza compound
- Finding the Universe of Craftsmanship: Individual Encounters in Imagination
- Japanese H3 rocket fails during launch of navigation satellite (video)
- Geminid shooting stars: One of 2025's most exciting meteor showers begins tonight
- The most effective method to Oversee Unsold SUVs in the Car Business
